Division of Cancer Epidemiology & Genetics

Publications

Understanding the Risks of Medical Radiation

Teams of epidemiologists, radiation dosimetrists, and statisticians in DCEG's Radiation Epidemiology Branch uncover the cancer risks associated with low-dose diagnostic and screening procedures and high-dose radiation therapy.

•	Read the full article in the March 2013 Linkage

Chatterjee Selected as Distinguished Lecturer

Dr. Nilanjan Chatterjee was chosen by the Harvard School of Public Health as the 2013 Myrto Lefkopoulou Distinguished Lecturer in recognition of his leadership in the field of biostatistics.

•	Read more details about this honor
•	View Dr. Chatterjee's biography

Newly Tenured: Nicolas Wentzensen

Dr. Nicolas Wentzensen is now a Senior Investigator in the Hormonal and Reproductive Epidemiology Branch.

•	Read an article about his research in Linkage
•	See Dr. Wentzensen's bio page

Understanding the Risks of Medical Radiation
Chatterjee Selected as Distinguished Lecturer
Newly Tenured: Nicolas Wentzensen

The Division of Cancer Epidemiology and Genetics (DCEG) is a research program of the National Cancer Institute (NCI), one of the National Institutes of Health (NIH). The Division is the world’s most comprehensive cancer epidemiology research group. Its renowned epidemiologists, geneticists, and biostatisticians conduct population and multidisciplinary research to discover the genetic and environmental determinants of cancer and new approaches to cancer prevention. The Division’s research impacts public health policy in the United States and around the world.

Linkage Newsletter